The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T H 17 lineage in humans

Although glioblastoma multiforme (GBM) is not an invariably cold tumor, checkpoint inhibition has largely failed in GBM. In order to investigate T cell–intrinsic properties that contribute to the resistance of GBM to endogenous or therapeutically enhanced adaptive immune responses, we sorted CD4 + a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2022-08, Vol.119 (34)
Hauptverfasser: Mitsdoerffer, Meike, Aly, Lilian, Barz, Melanie, Engleitner, Thomas, Sie, Christopher, Delbridge, Claire, Lepennetier, Gildas, Öllinger, Rupert, Pfaller, Monika, Wiestler, Benedikt, Rad, Roland, Meyer, Bernhard, Knier, Benjamin, Schmidt-Graf, Friederike, Gempt, Jens, Korn, Thomas
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although glioblastoma multiforme (GBM) is not an invariably cold tumor, checkpoint inhibition has largely failed in GBM. In order to investigate T cell–intrinsic properties that contribute to the resistance of GBM to endogenous or therapeutically enhanced adaptive immune responses, we sorted CD4 + and CD8 + T cells from the peripheral blood, normal-appearing brain tissue, and tumor bed of nine treatment-naive patients with GBM. Bulk RNA sequencing of highly pure T cell populations from these different compartments was used to obtain deep transcriptomes of tumor-infiltrating T cells (TILs). While the transcriptome of CD8 + TILs suggested that they were partly locked in a dysfunctional state, CD4 + TILs showed a robust commitment to the type 17 T helper cell (T H 17) lineage, which was corroborated by flow cytometry in four additional GBM cases. Therefore, our study illustrates that the brain tumor environment in GBM might instruct T H 17 commitment of infiltrating T helper cells. Whether these properties of CD4 + TILs facilitate a tumor-promoting milieu and thus could be a target for adjuvant anti-T H 17 cell interventions needs to be further investigated.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.2206208119